Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Oncopolicy Forum 2012 /
Role of ECCO in the development of personalised oncology treatment

24th - 29th Nov 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 22.10.12
Views: 3931

Kathy Oliver – ECCO Patient Advisory Committee; Prof Julio Celis – ECCO Policy Committee; Prof Cornelis van de Velde – President of ECCO

The panel discuss the level of understanding of personalised oncology treatments among the general public and explain what steps must be taken to improve this.


There are many advantages to a more individualised approach to oncology; however for this approach to succeed it is essential that all stakeholders are engaged and contribute towards its development.


The panel explain how Horizon 2020 will give oncologists an opportunity to contribute to funding policy, consider the need for more advanced data management systems to deal with the increase in data associated with a multidisciplinary approach to oncology and emphasise the need for a platform for Europe-wide treatment guidelines.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation